A new peer-reviewed systematic review in Pharmaceuticals (October 2024) examined clinical and preclinical research on CBD (cannabidiol) used without THC for pain. The authors screened 500+ papers and analyzed 40 studies. Their takeaway: across animal and early human studies, CBD showed analgesic and anti-inflammatory activity, with emerging relevance for chronic pain and osteoarthritis.
What this means for readers: If you’re exploring CBD as part of a broader wellness plan, look for zero THC, third-party tested products, like Blue Sky CBD and discuss any changes with your healthcare provider—especially if you take other medications.
